Colgate-Palmolive (India) Limited (COLPAL) AI Stock Analysis

• Market Cap: ₹527.64B
• Dividend Yield: 2.42%
• Average Volume (3M): 17.80K
• Price to Earnings (P/E): 43.6
• Beta (1Y): 0.78
• Revenue Growth: -2.06%
• EPS Growth: -9.74%
• Country: IN
• Employees: 2,221
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 12.20
• Shares Outstanding: 271,985,630
• 10 Day Avg. Volume: 22,363
• 30 Day Avg. Volume: 17,801
• PEG Ratio: 5.21
• Price to Book (P/B): 38.41
• Price to Sales (P/S): 10.58
• P/FCF Ratio: 48.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 49.56
• Revenue Forecast (FY): ₹59.77B

• Rating: 70 Outperform
• Price Target: ₹2,134.00 ▲(2.74% Upside)
• Action: Upgraded Date: 11/01/25
• Date: Action: Upgraded 11/01/25

Colgate-Palmolive (India) Limited's strong financial performance is the most significant factor, showcasing robust revenue growth and profitability. However, technical indicators suggest potential bearish momentum, and the high P/E ratio indicates a relatively expensive valuation. The absence of earnings call data and corporate events limits further insights.

Positive Factors

High Profitability

Colpal's very high gross and operating margins indicate durable pricing power, efficient manufacturing and a profitable product mix. Such structural margin strength supports steady internal funding for marketing and capex, enabling sustained market share and reinvestment over months.

Low Leverage / Strong Balance Sheet

Extremely low leverage and a healthy equity ratio provide financial flexibility to invest, weather demand cycles, and pursue initiatives without refinancing risk. This balance sheet strength materially reduces solvency risk over a multi-month horizon.

Reliable Cash Generation

Near-par conversion of profits to cash and double-digit free cash flow growth indicate predictable internal funding for dividends, working capital and expansion. Strong cash conversion underpins durable capital allocation and resilience to short-term demand shocks.

Negative Factors

Recent Revenue & EPS Weakness

Recent negative revenue and EPS growth point to near-term demand or volume softness that could persist for several quarters. Slower top-line and earnings momentum can limit margin expansion and reduce headroom for marketing-led share gains across the fiscal half-year.

Category Concentration Risk

Heavy reliance on oral care concentrates revenue and exposes the company to category-specific competition, pricing pressure, or regulatory changes. Limited product diversification can cap growth and increase vulnerability to structural shifts in a single category over months.

Limited Forward Disclosure

Absence of earnings call detail or explicit guidance reduces visibility into management's outlook and plans. For investors and partners, limited disclosure makes forecasting and risk assessment harder across the next few quarters, raising execution uncertainty.

Colgate-Palmolive (India) Limited Business Overview & Revenue Model

Company Description

Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, oil pulling products, mouthwashes, and dental gels, as well as specialty products under the Colgate brand name. It also provides soaps, cosmetics, and toilet preparations. The company offers a range of personal care products, such as shower gels and liquid hand washes under the Palmolive brand name. It also exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India.

How the Company Makes Money

Colgate-Palmolive (India) Limited primarily makes money by selling branded consumer products in India, with revenue recognized from the sale of finished goods to a broad base of trade customers (distributors/wholesalers and retailers), modern trade accounts, and online channels, which then sell onward to end consumers. The largest revenue stream is typically oral care: toothpaste (a high-frequency replenishment category) and toothbrushes (a repeat-purchase category), supported by brand-led pricing, product mix (different price tiers/pack sizes), and continuous marketing that helps sustain volume and market share. The company’s earnings are driven by (1) volume growth through household penetration and repeat purchases, (2) pricing and premiumization (introducing higher-value variants and maintaining a portfolio across value to premium price points), and (3) distribution reach and execution across urban and rural markets. Profitability depends on gross margin management—especially procurement costs for key raw/packaging materials, manufacturing efficiency, and supply-chain productivity—along with disciplined spending on advertising and consumer promotions to support brand equity and demand. Any other income streams (if present in reported financials) would generally be ancillary compared with product sales; if specific contributions from such items are not publicly detailed, they cannot be reliably quantified here and are therefore null.

Colgate-Palmolive (India) Limited Financial Statement Overview

Summary

Colgate-Palmolive (India) Limited exhibits robust financial health with strong revenue growth and high profitability margins. The company maintains minimal reliance on debt and demonstrates solid cash flow generation, supporting future expansion and investment.

Income Statement

Colgate-Palmolive (India) Limited shows strong performance with consistent revenue growth, evidenced by a Revenue Growth Rate of 6.33% in the latest year. The company maintains high profitability with a Gross Profit Margin of 69.89% and a Net Profit Margin of 23.78% for 2025. EBIT and EBITDA margins are robust at 48.87% and 32.42%, respectively, indicating efficient operations.

Balance Sheet

The balance sheet reflects solid equity strength with an Equity Ratio of 55.12% in 2025. The Debt-to-Equity Ratio is low at 0.037, indicating minimal leverage, which reduces financial risk. However, the Return on Equity is moderate at 86.31%, suggesting opportunities to enhance shareholder returns.

Cash Flow

The company demonstrates solid cash flow with a Free Cash Flow to Net Income Ratio of 0.92 for 2025, showing strong cash generation relative to profit. The Operating Cash Flow to Net Income Ratio is 0.97, indicating efficient conversion of profits into cash. Free Cash Flow Growth Rate is healthy at 17.78%, supporting further investment capabilities.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	58.55B	60.40B	56.80B	52.26B	50.95B	48.38B
Gross Profit	39.20B	42.22B	30.85B	26.08B	31.10B	24.94B
EBITDA	19.26B	19.58B	19.58B	15.89B	15.92B	15.40B
Net Income	13.26B	14.37B	13.24B	10.47B	10.78B	10.35B
Balance Sheet
Total Assets	31.78B	30.19B	31.97B	28.83B	29.02B	28.94B
Cash, Cash Equivalents and Short-Term Investments	13.47B	6.68B	8.89B	8.06B	7.24B	2.97B
Total Debt	1.06B	608.40M	717.49M	689.60M	830.54M	911.75M
Total Liabilities	15.95B	13.54B	13.22B	11.67B	11.67B	17.28B
Stockholders Equity	15.82B	16.64B	18.74B	17.16B	17.35B	11.66B
Cash Flow
Free Cash Flow	9.61B	13.23B	11.23B	11.06B	15.76B	7.26B
Operating Cash Flow	9.97B	13.94B	11.99B	11.76B	16.26B	7.84B
Investing Cash Flow	3.81B	559.70M	792.39M	-75.40M	-1.08B	713.53M
Financing Cash Flow	-7.40B	-16.71B	-11.95B	-10.87B	-10.91B	-9.56B

Colgate-Palmolive (India) Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2077.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:COLPAL, the sentiment is Negative. The current price of 2077 is below the 20-day moving average (MA) of 2167.51, below the 50-day MA of 2139.01, and below the 200-day MA of 2233.66, indicating a bearish trend. The MACD of -27.64 indicates Positive momentum. The RSI at 30.92 is Neutral, neither overbought nor oversold. The STOCH value of 2.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:COLPAL.

Colgate-Palmolive (India) Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COLPAL	70 Outperform	₹527.64B	43.58	―	2.42%	-2.06%	-9.74%
MARICO	69 Neutral	₹973.54B	54.57	―	1.42%	22.56%	4.73%
HINDUNILVR	67 Neutral	₹5.11T	20.59	―	1.84%	2.94%	6.05%
DABUR	66 Neutral	₹813.33B	39.88	―	1.62%	2.68%	1.07%
PGHH	63 Neutral	₹330.14B	54.70	―	2.08%	8.28%	11.65%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GODREJCP	59 Neutral	₹1.06T	62.79	―	1.67%	5.77%	―

Colgate-Palmolive (India) Limited Corporate Events

Colgate-Palmolive, Haryana Government Tie Up to Deliver Oral Health Education to 5.7 Million Students

Colgate-Palmolive (India) Limited has partnered with the Government of Haryana to expand its Bright Smiles, Bright Futures oral health education initiative to 5.7 million schoolchildren across the state. The program, which already reaches more than 10 million children annually in India, will be embedded into both public and private school systems in Haryana to strengthen awareness and preventive oral hygiene practices.

The collaboration is positioned as a systemic shift from one-off awareness efforts to sustained, curriculum-linked action designed to shape lifelong habits during children’s formative years. By integrating oral health education into existing educational infrastructure, Colgate and the state government aim to deliver long-term public health benefits, bolster children’s confidence and development, and reinforce Colgate’s role as a key partner in oral health promotion at scale.